Literature DB >> 1348449

Differences in breast cancer risk factors to neu (c-erbB-2) protein overexpression of the breast tumor.

H F Treurniet1, M A Rookus, H L Peterse, A A Hart, F E van Leeuwen.   

Abstract

To investigate whether overexpression of the neu protein in breast tumors differentiates risk factor patterns for breast cancer, neu protein overexpression was determined in 296 breast carcinomas of patients participating in an ongoing population-based case-control study. Risk factor information on these patients and 737 controls was obtained during home interviews. Most breast cancer risk factors showed similar associations with neu-positive and neu-negative tumors, but remarkable differences were found for breast-feeding and age at first full-term pregnancy. In contrast to the slightly protective effect of breast-feeding in the neu-negative group, the risk of neu-positive breast cancer was 4.2-fold increased in women who ever breast-fed. Increasing age at first full-term pregnancy was positively associated with both neu-positive and neu-negative breast cancer, but the association was about 2 times stronger for neu-positive tumors. We conclude that neu oncogene overexpression of the breast tumor seems to be associated with a distinct risk factor pattern.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1348449

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  4 in total

1.  Sustained trophism of the mammary gland is sufficient to accelerate and synchronize development of ErbB2/Neu-induced tumors.

Authors:  M D Landis; D D Seachrist; F W Abdul-Karim; R A Keri
Journal:  Oncogene       Date:  2006-01-23       Impact factor: 9.867

2.  The protective effect of parity in hormone receptor-positive, Ki-67 expressing breast cancer.

Authors:  Se Kyung Lee; Seok Won Kim; Sang-Ah Han; Won Ho Kil; Jeong Eon Lee; Seok Jin Nam
Journal:  World J Surg       Date:  2014-05       Impact factor: 3.352

3.  The Carolina Breast Cancer Study: integrating population-based epidemiology and molecular biology.

Authors:  B Newman; P G Moorman; R Millikan; B F Qaqish; J Geradts; T E Aldrich; E T Liu
Journal:  Breast Cancer Res Treat       Date:  1995-07       Impact factor: 4.872

4.  Correlation of breast cancer risk factors with HER-2/neu protein overexpression according to menopausal and estrogen receptor status.

Authors:  Nikos Tsakountakis; Elias Sanidas; Efstathios Stathopoulos; Maria Kafousi; Nektaria Anogiannaki; Vasilis Georgoulias; Dimitris D Tsiftsis
Journal:  BMC Womens Health       Date:  2005-02-04       Impact factor: 2.809

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.